思创医惠欺诈发行案公安接棒 8亿可转债中信证券保荐

Core Viewpoint - The company, Sichuang Medical Technology Co., Ltd., is under investigation for alleged fraudulent issuance of securities and violations of information disclosure regulations, leading to potential administrative penalties and market bans for its executives [1][2][3]. Group 1: Investigation and Regulatory Actions - On August 15, 2025, the company received a notice from the Hangzhou Public Security Bureau regarding the collection of evidence related to a fraud investigation [1]. - The Zhejiang Securities Regulatory Bureau has completed its investigation and plans to impose administrative penalties on the company and its executives for fraudulent issuance and information disclosure violations [1][2]. - The company is cooperating with the investigation and has acknowledged the allegations of fabricating significant false content in its public offering documents and false records in its annual reports for 2019 and 2020 [1][2]. Group 2: Penalties and Fines - The proposed penalties include a fine of 8.17 million yuan for the company, along with individual fines for executives, including 5 million yuan for Zhang Lizhong and 2 million yuan each for Wang Lin and Sun Xinjun [2]. - The total fines for the company amount to 85.7 million yuan, which includes penalties for both fraudulent issuance and information disclosure violations [2]. - Zhang Lizhong, the former chairman and general manager, faces a 10-year market ban, preventing him from engaging in securities business or holding executive positions in any public companies during this period [3]. Group 3: Fundraising History - The company has raised a total of 3.028 billion yuan through five fundraising rounds, including an initial public offering (IPO) that raised 986 million yuan [3]. - The company’s IPO was conducted on April 30, 2010, with a share price of 58.00 yuan, resulting in a net fundraising amount of approximately 934.08 million yuan after expenses [3]. - Subsequent fundraising activities included two private placements and a convertible bond issuance, contributing to the total raised amount [3][5].